# A Novel Therapeutic Treatment of Pyoderma Gangrenosum

> **NCT05120726** · PHASE4 · TERMINATED · sponsor: **Louisiana State University Health Sciences Center in New Orleans** · enrollment: 5 (actual)

## Conditions studied

- Pyoderma Gangrenosum

## Interventions

- **BIOLOGICAL:** Dehydrated human amnion/chorion membrane

## Key facts

- **NCT ID:** NCT05120726
- **Lead sponsor:** Louisiana State University Health Sciences Center in New Orleans
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-06-02
- **Primary completion:** 2024-11-18
- **Final completion:** 2024-11-18
- **Target enrollment:** 5 (ACTUAL)
- **Why stopped:** The study was closed prior to completion because of difficulties in recruiting eligible participants. Despite outreach efforts, enrollment remained insufficient to meet anticipated study endpoints.
- **Last updated:** 2025-10-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05120726

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05120726, "A Novel Therapeutic Treatment of Pyoderma Gangrenosum". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT05120726. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*